What is the appropriate fosfomycin dosage for treating an uncomplicated urinary tract infection?

Fosfomycin Dosage for Uncomplicated Urinary Tract Infection

For uncomplicated cystitis in adult women, administer a single oral dose of fosfomycin tromethamine 3 grams, mixed with water and taken on an empty stomach or with food. This single-dose regimen is recommended by the IDSA, EAU, AUA, and ACP as first-line therapy when trimethoprim-sulfamethoxazole resistance exceeds 20% in your community. 1, 2

Standard Dosing Protocol

• Mix one 3-gram sachet with 90–120 mL (3–4 ounces) of water before ingesting; never take the granules in dry form. 2
• The dose may be taken with or without food, though absorption is modestly reduced with high-fat meals (bioavailability drops from 37% fasting to 30% fed), but urinary concentrations remain therapeutic for the same 24–48 hour duration. 2
• Do not repeat the dose; a single 3-gram administration is the evidence-based regimen for uncomplicated lower UTI. 1, 2

Clinical Efficacy

• Clinical cure is achieved in approximately 91% of women treated with single-dose fosfomycin, with bacteriological eradication rates of 75–90% assessed 5–11 days post-treatment. 1, 3
• Therapeutic urinary concentrations (>128 mg/L) persist for 24–48 hours after a single dose, which is sufficient to eradicate most uropathogens causing uncomplicated cystitis. 4, 3
• Fosfomycin demonstrates comparable clinical efficacy to 3–7 day courses of ciprofloxacin, nitrofurantoin, or trimethoprim-sulfamethoxazole, making it a convenient and effective alternative. 3, 5

Indications and Patient Selection

• Use fosfomycin for uncomplicated cystitis only—defined as dysuria, frequency, and urgency without fever >38°C, flank pain, nausea, vomiting, or costovertebral-angle tenderness. 1
• Fosfomycin is particularly appropriate when local trimethoprim-sulfamethoxazole resistance exceeds 20% or when the patient has used that agent in the prior 3 months. 1
• It retains excellent activity against multidrug-resistant organisms, including ESBL-producing E. coli, vancomycin-resistant Enterococcus, and MRSA, with resistance rates around 2.6% in initial infections. 1, 6

Absolute Contraindications

• Do not use fosfomycin for suspected or confirmed pyelonephritis (fever, flank pain, systemic symptoms), because tissue penetration is insufficient for upper-tract infections; prescribe a fluoroquinolone or parenteral cephalosporin instead. 1, 2
• Do not use fosfomycin for complicated UTIs (male patients, pregnancy with systemic symptoms, indwelling catheters, urological abnormalities, immunosuppression). 1
• Routine use in men is not recommended due to limited efficacy data in this population. 1

Management of Treatment Failure

• If symptoms persist after 2–3 days or recur within 2 weeks, obtain a urine culture with susceptibility testing immediately. 1
• Switch to an alternative agent for a full 7-day course: nitrofurantoin 100 mg twice daily for 5 days, trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days (if susceptible), or a fluoroquinolone only if culture-proven resistance to first-line agents. 1
• Do not repeat the single fosfomycin dose; assume the pathogen is resistant and select a different antibiotic class. 1

Diagnostic Recommendations

• Routine urine culture is not required for otherwise healthy women presenting with typical cystitis symptoms (dysuria, frequency, urgency) without vaginal discharge. 1
• Obtain culture and susceptibility testing when:
  • Symptoms persist after completing therapy
  • Symptoms recur within 2–4 weeks
  • Fever >38°C, flank pain, or costovertebral-angle tenderness suggests pyelonephritis
  • The patient is pregnant
  • There is a history of recurrent infections or prior resistant organisms 1

Common Pitfalls to Avoid

• Do not prescribe fosfomycin for "borderline" upper-tract symptoms (even mild flank pain or low-grade fever); any suspicion of pyelonephritis mandates a fluoroquinolone or cephalosporin because fosfomycin lacks adequate renal tissue penetration. 1
• Do not obtain routine post-treatment urine cultures in asymptomatic patients; symptom resolution alone confirms clinical cure, and unnecessary cultures promote overtreatment of asymptomatic bacteriuria. 1
• Do not treat asymptomatic bacteriuria in non-pregnant, non-catheterized patients, as this provides no clinical benefit and accelerates antimicrobial resistance. 1

Special Populations

• Pregnancy: Fosfomycin is safe throughout all trimesters (pregnancy category B) and is recommended for both asymptomatic bacteriuria and symptomatic cystitis in pregnant women as a single 3-gram dose. 1, 4
• Renal impairment: No dose adjustment is necessary for mild-to-moderate renal dysfunction (eGFR ≥30 mL/min/1.73 m²); however, the elimination half-life increases from 5.7 hours to 40–50 hours in anuric patients, so use with caution in severe renal failure. 1, 2
• Elderly patients: No dose adjustment is required; 24-hour urinary drug concentrations remain unchanged in older adults. 2

Adverse Effects

• Gastrointestinal disturbances (diarrhea, nausea) are the most commonly reported side effects, occurring in 5.6–28% of patients. 1
• Serious adverse events are rare; fosfomycin is generally well tolerated with minimal disruption to intestinal flora, reducing the risk of Clostridioides difficile infection compared with fluoroquinolones or cephalosporins. 1